SURGERY PARTNERS INCSGRY
ASignal's systematic analysis rates SGRY as Bearish.
Reflects the latest available analysis · analyzed Sep 12, 2026
The case on SGRY
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Price near upper end of Bollinger Bands suggesting potential upside momentum
- Positive MACD histogram expansion indicating strengthening momentum
- Current ratio of 1.95x and quick ratio of 1.44x reflect solid short-term liquidity
- Free cash flow of $183.56M indicates operational cash generation
- Negative net profit margin (-2.63%) and low return on equity (2.32%)
- High debt-to-equity ratio of 1.17x indicating elevated leverage
- Revenue growth of only 2.70% year-over-year suggests slow top-line expansion
- Forward P/E of 22.92x may be high relative to slow growth and unprofitable earnings
- No Reddit mentions indicating lack of retail investor interest
See the full verdict on SGRY
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes SGRY
Most investors never get a second opinion, let alone several. ASignal runs SGRY past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.